Finance committee  I have to confess that Brian Pallister has made me a bit partial to Winnipeg right now.

Finance committee  Thank you very much. Thank you for the opportunity to join you today. Messenger RNA is the most effective vaccine technology on the planet. In the worldwide race for a COVID vaccine, messenger RNA was the fastest by months. It is the most effective at 95% efficacy. It will be t

Industry committee  We were not seeking a $150-million grant. We were seeking a $150-million deposit so that we could engage our manufacturing plant and purchase the required raw materials in order to make 50 million doses of vaccines in 2021. The Canadian government chose not to respond to that, so

Industry committee  That is correct.

Industry committee  I received a phone call from Minister Champagne on Saturday, and that was the first contact we received. We did not discuss that particular letter. We discussed other infrastructure dialogue.

Industry committee  Yes, I agree with those recommendations.

Industry committee  The design was completed in March of 2020.

Industry committee  That is correct. We had a GMP facility at Sunnybrook Research Institute.

Industry committee  Certainly. In the second half of April, we were formally invited by the strategic innovation fund to make an application for their review. We were told at that time that, of all of the applications, there would be a short list and that the short list would be contacted within a

Industry committee  Certainly. We designed the vaccine. We took that vaccine into animal trials where we tested safety and we tested efficacy. We did two efficacy trials: one in mice and one in hamsters. We did a number of safety trials.

Industry committee  Certainly. We did an initial safety trial with the University of Toronto, and that would have been conducted in April. We published that data, I believe it was in June, and we did additional follow-up safety trials that summer with Charles River Laboratories in Quebec. In conjunc

Industry committee  Health Canada has responded very quickly with regard to reviewing and giving us the authorization to proceed with our clinical trial.

Industry committee  We would welcome the federal support, but being at the point of being able to do the production and have the offtake agreements with the provinces, we now have the ability to go to the capital markets and to raise sufficient capital funds to carry forward our plan, regardless of

Industry committee  That will be disclosed in the coming 10 days.

Industry committee  We provide the National Research Council regular updates on our progress with regard to the phase one clinical trial. We provided them the full package that was also submitted to Health Canada, in which we received our authorization to proceed, and we provided them full access to